MARKET

ADMA

ADMA

ADMA Biologics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.830
-0.040
-1.39%
After Hours: 2.850 +0.02 +0.71% 17:51 07/10 EDT
OPEN
2.880
PREV CLOSE
2.870
HIGH
2.890
LOW
2.800
VOLUME
2.23M
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.450
MARKET CAP
244.36M
P/E (TTM)
-3.1992
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ADMA stock price target is 9.83 with a high estimate of 15.00 and a low estimate of 6.00.

EPS

ADMA News

More
Is the Options Market Predicting a Spike in ADMA Stock?
Zacks · 3d ago
ADMA Biologics Commences Plasma Collection at its Tennessee Facility, Filed for Approval of a Second Plasma Collection Center
Benzinga · 4d ago
ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., July 06, 2020 -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company.
GlobeNewswire · 4d ago
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?
Simply Wall St. · 07/03 15:13
Liminal BioSciences up big on start of convalescent plasma collection
Seeking Alpha - Article · 07/01 19:19
ADMA Biologics: Benefit From Production Ramp
Seeking Alpha - Article · 06/30 16:34
RAD, INO among premarket gainers
Seeking Alpha - Article · 06/25 12:14
Hedge Funds Have Never Been This Bullish On ADMA Biologics Inc (ADMA)
Insider Monkey · 06/23 17:49

Industry

Biotechnology & Medical Research
-0.77%
Pharmaceuticals & Medical Research
-0.48%

Hot Stocks

Symbol
Price
%Change

About ADMA

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.
More

Webull offers kinds of ADMA Biologics Inc stock information, including NASDAQ:ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.